lansoprazole has been researched along with Nutritional Disorders in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kilbane, MT | 1 |
| O'Keane, M | 1 |
| Morrin, M | 1 |
| Flynn, M | 1 |
| McKenna, MJ | 1 |
1 other study available for lansoprazole and Nutritional Disorders
| Article | Year |
|---|---|
The double-edged sword of vitamin D in Ireland: the need for public health awareness about too much as well as too little.
Topics: Adult; Aged; Calcium, Dietary; Dietary Supplements; Female; Humans; Ireland; Lansoprazole; Male; Mid | 2014 |